Multidrug resistance (MDR) is a significant challenge in the treatment of cancer. It refers to the ability of cancer cells to resist the effects of a wide range of chemotherapeutic drugs. This resistance hampers the efficacy of treatment, leading to treatment failure and disease progression. MDR can occur due to various mechanisms within the cancer cells that either reduce the uptake or increase the efflux of drugs, among other strategies to avoid drug cytotoxicity.